Clues to Brain Development and Disease Emerge from 3D Epigenome Study
UCSF researchers are finding new clues to how neuropsychiatric disorders unfold by focusing on the role of a little-studied form of DNA in early brain development.
University of California San Francisco
UCSF Health Executive Council Welcomes Two New Members
UCSF Health has added two impressive members to its Executive Council, which serves as the health system’s business advisory board.
Inhalable Treatment Enhances Regeneration in Lung Fibrosis Model
A new study highlights the potential of a novel, inhalable regenerative therapy for the treatment of idiopathic pulmonary fibrosis.
Rapid COVID-19 Test Shows Promise in Community Test Setting
Preliminary data from a study by UCSF and Chan Zuckerberg Biohub scientists suggests that new rapid COVID-19 tests – if used correctly and alongside existing gold-standard PCR tests – could be a valuable tool to accelerate the COVID-19 public health response.
Struggling Sea Lions May Benefit from UCSF Neuroscience Research
A cellular therapy for epilepsy developed at UCSF has been employed for the first time in a sea lion with intractable seizures caused by ingesting toxins from algal blooms.
DNA Test Identifies Genetic Causes of Severe Fetal and Newborn Illness
A new study by University of California researchers shows the promise of high-throughput DNA-sequencing technologies to improve prenatal diagnosis and pregnancy outcomes for women who have experienced an abnormal prenatal ultrasound.
UCSF, Fortanix, Intel, and Microsoft Azure Utilize Privacy-Preserving Analytics to Accelerate AI in Health Care
UC San Francisco’s Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure have formed a collaboration to establish a confidential computing platform with privacy-preserving analytics to accelerate the development and validation of clinical algorithms.
New Gift Fuels Precision Medicine Approaches to Diabetes
A generous gift of $1 million from an anonymous donor recently created the Breakthrough Initiative in Type 1 Diabetes Precision Medicine and Discovery.